Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance
Go back to Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 276.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $276.98 | 52 Week High | $139.79 | |||
| Open | $276.98 | 52 Week Low | $82.07 | |||
| Day High | $276.98 | P/E | 644.14 | |||
| Day Low | $276.98 | EPS | $0.43 | |||
| Volume | 5,511 | |||||

